about
Antithrombin III for critically ill patientsAntithrombin III for critically ill patientsApolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infectionHDL in sepsis - risk factor and therapeutic approachUpdate on adrenal insufficiency in patients with liver cirrhosisScreening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 -174G>C polymorphism.Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages.Serum lipids and lipoproteins in malaria--a systematic review and meta-analysisLow HDL levels in sepsis versus trauma patients in intensive care unit.Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants.The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.The hepatoadrenal syndrome: a common yet unrecognized clinical condition.Intestine-specific Mttp deletion decreases mortality and prevents sepsis-induced intestinal injury in a murine model of Pseudomonas aeruginosa pneumoniaThe lipid-bound apolipoprotein A-I cysteine mutant (N74C) inhibits the activation of NF-κB, JNK and p38 in endotoxemic mice and RAW264.7 cells.CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children.Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever.Serum levels of apolipoprotein A-I and high-density lipoprotein can predict organ failure in acute pancreatitis.Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock.Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill PatientsPrognostic Implications of Serum Lipid Metabolism over Time during SepsisLipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated RatsChronic prehepatic portal hypertension in the rat: is it a type of metabolic inflammatory syndrome?The binding capability of plasma phospholipid transfer protein, but not HDL pool size, is critical to repress LPS induced inflammation.Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patientsHigh density lipoprotein protects against polymicrobe-induced sepsis in miceProtein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells.Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controlsApolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats.Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.Cholesterol levels and long-term rates of community-acquired sepsis.Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysisNosocomial infections after severe trauma are associated with lower apolipoproteins B and AII.High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injuryHDL in innate and adaptive immunity.Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men.Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation.Advances in high-density lipoprotein physiology: surprises, overturns, and promises.Increased expression of ApoA1 after neuronal injury may be beneficial for healing.
P2860
Q24186159-C99E53E9-8553-471B-83E1-971912189625Q24242053-D7244AC1-1CD5-4401-8CF7-4BEA266CB26FQ24654997-7E3AC87A-67FB-4654-9935-E9DD049A382DQ26777964-CA766742-12F5-4233-9AAE-785E5CD899EBQ27008289-66FC464B-34D1-4E15-9DA6-AE2539438B0AQ33274516-273D3395-CA4C-49A0-92AE-DC88DC15B0BDQ33389832-DC879A1A-4695-4999-A729-DE96EDADC5ABQ33642820-A903082C-FBB9-4A95-9083-747BF98D77EFQ33770014-96EA687C-4FBF-46F6-A824-6F3A2A0DEB8FQ34028660-3143C6D8-D29B-49E4-9007-9F3341B6E272Q34053131-8B69AD23-B498-4380-8435-EC59FD3DEA96Q34340237-AF653602-D7B2-43DA-AAC9-F3EB6408D39BQ34474151-2B0ACCFD-89F2-4896-8B3C-658693E679DCQ34516452-EBC3FB56-0937-40D6-B1AA-9567C71BE324Q34604256-320F5E50-6A27-4AB6-BBE0-89A81E54C072Q34731730-71BC31C9-F21F-4A73-9CEC-A6E429E2A780Q35099718-AD9D1D84-B85E-490F-B2C3-A130C64BC0A5Q35187349-103A518E-0F7E-498D-92AA-27CFB30D9E0DQ35733679-C431916F-48B6-42A4-A422-4A3BCAFB5112Q35957788-45506DE8-6FE7-4A96-9DCC-EB628F4C26C3Q36006620-1B8177FC-0AF6-4363-88D0-6D9913FDE612Q36015844-C9056492-CFAA-49E4-B364-70AFECE4B8FFQ36447185-03394CE9-3766-445E-9E40-2C3972FE1C2EQ36487408-88FA3C7A-8041-47B9-BDB2-F1431F266F35Q36560015-6014A1C0-F866-4599-B411-D4E1C7670C90Q36856037-532CAEA4-885E-44E4-8F92-D33DC8C64FE5Q36947699-FB3EB026-4D44-432B-9D71-687F69757E7DQ37089094-FE38BCF5-ABFF-489A-8A44-BCE2050056BCQ37273794-A504A546-A46A-4230-8A58-9457546DF503Q37298363-EE515EBB-16F8-4303-B4C3-B2421F1A4055Q37430645-B0A27A4E-DC42-4E33-9E66-3FEF596DC322Q37529598-0B3CCA2B-8F53-49D6-AC96-A5B9D842E127Q37542828-68E1E426-2D5D-4BE6-A6A8-88D4CD5624B9Q37555546-1E9465F1-0EAE-408B-958A-24EB7005E498Q37742226-95077196-0BE4-4E77-BA77-182EF30D2DCCQ38220759-6F21991F-0AE3-47AD-BA7F-B6198F7704DDQ38326541-549AB6B1-8F75-487F-B247-9EC52CEEF73AQ38520159-B76D6829-9B7D-490D-9696-EC32DEA553D4Q38623588-0F084057-1D86-4196-B5D0-B974F333B88BQ38741473-B3AF7545-0390-436A-9B1C-8227690F5D77
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Lipoprotein metabolism in patients with severe sepsis.
@en
Lipoprotein metabolism in patients with severe sepsis.
@nl
type
label
Lipoprotein metabolism in patients with severe sepsis.
@en
Lipoprotein metabolism in patients with severe sepsis.
@nl
prefLabel
Lipoprotein metabolism in patients with severe sepsis.
@en
Lipoprotein metabolism in patients with severe sepsis.
@nl
P2093
P1476
Lipoprotein metabolism in patients with severe sepsis.
@en
P2093
Eric C J M Heezius
Geesje M Dallinga
Henk J van Leeuwen
Jan Verhoef
Kok P M van Kessel
P304
P356
10.1097/01.CCM.0000059724.08290.51
P407
P577
2003-05-01T00:00:00Z